bioassay

生物测定
  • 文章类型: Journal Article
    富血小板纤维蛋白(PRF),分馏血液的凝固血浆,广泛用于支持牙科组织再生,以及潜在的细胞和分子机制越来越被理解。牙周结缔组织稳定表达CXCL8,一种吸引粒细胞和淋巴细胞的趋化因子,支持稳态免疫。即使PRF被认为可以抑制炎症,不应排除PRF增加牙龈成纤维细胞中CXCL8的表达。为了检验这个假设,我们进行了一项生物测定,其中牙龈成纤维细胞暴露于PRF裂解物和各自的血清。我们在这里显示PRF裂解物和,在较小程度上,PRF血清增加牙龈成纤维细胞CXCL8的表达,经免疫测定证实。SB203580,p38丝裂原活化蛋白激酶的抑制剂,降低CXCL8表达。始终如一,PRF裂解物和,到一个较弱的范围,PRF血清也引起牙龈成纤维细胞中p38的磷酸化。假设PRF是生长因子的丰富来源,TGF-β受体I型激酶抑制剂SB431542降低了PRF诱导的CXCL8的表达和翻译。研究结果表明,PRF裂解物和各自的血清通过激活牙龈成纤维细胞中的TGF-β和p38信号传导来驱动CXCL8表达。
    Platelet-rich fibrin (PRF), the coagulated plasma of fractionated blood, is widely used to support tissue regeneration in dentistry, and the underlying cellular and molecular mechanisms are increasingly being understood. Periodontal connective tissues steadily express CXCL8, a chemokine that attracts granulocytes and lymphocytes, supporting homeostatic immunity. Even though PRF is considered to dampen inflammation, it should not be ruled out that PRF increases the expression of CXCL8 in gingival fibroblasts. To test this hypothesis, we conducted a bioassay where gingival fibroblasts were exposed to PRF lysates and the respective serum. We show here that PRF lysates and, to a lesser extent, PRF serum increased the expression of CXCL8 by the gingival fibroblasts, as confirmed by immunoassay. SB203580, the inhibitor of p38 mitogen-activated protein kinase, reduced CXCL8 expression. Consistently, PRF lysates and, to a weaker range, the PRF serum also caused phosphorylation of p38 in gingival fibroblasts. Assuming that PRF is a rich source of growth factors, the TGF-β receptor type I kinase inhibitor SB431542 decreased the PRF-induced expression and translation of CXCL8. The findings suggest that PRF lysates and the respective serum drive CXCL8 expression by activating TGF-β and p38 signaling in gingival fibroblasts.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在一项全国性的新鲜调查中,解冻,美国牧场饲养的羊肉和猪肉,通过随机多阶段抽样(750猪肉,750只羊肉)从美国10个主要地理区域的250家肉类零售店获得。每个样品由从零售肉箱购买的最少500g的肉组成。为了检测可行的弓形虫,在小鼠中对1500个样品中的每一个的50g肉样品进行生物测定。从750只羔羊样品中的2只中分离出可行的弓形虫(未称重:0.19%,0.00-0.46%;加权:0.04%,0.00-0.11%)和750个猪肉样品中的1个(未加权:0.12%,0.00-0.37%;加权:0.18%,0.00-0.53%)样品。总的来说,这些零售肉类中可行的弓形虫的患病率非常低。然而,消费者,尤其是孕妇,应该知道,他们可以从摄入未煮熟的肉中获得弓形虫感染。将肉类烹饪至66°C的内部温度会杀死弓形虫。
    In a national survey of fresh, unfrozen, American pasture-raised lamb and pork, the prevalence of viable Toxoplasma gondii was determined in 1500 samples selected by random multistage sampling (750 pork, 750 lamb) obtained from 250 retail meat stores from 10 major geographic areas in the USA. Each sample consisted of a minimum of 500g of meat purchased from the retail meat case. To detect viable T. gondii, 50g meat samples of each of 1500 samples were bioassayed in mice. Viable T. gondii was isolated from 2 of 750 lamb samples (unweighted: 0.19%, 0.00-0.46%; weighted: 0.04%, 0.00-0.11%) and 1 of 750 pork samples (unweighted: 0.12%, 0.00-0.37%; weighted: 0.18%, 0.00-0.53%) samples. Overall, the prevalence of viable T. gondii in these retail meats was very low. Nevertheless, consumers, especially pregnant women, should be aware that they can acquire T. gondii infection from ingestion of undercooked meat. Cooking meat to an internal temperature of 66°C kills T. gondii.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    消化系统的各种临床症状,如传染性,炎症,和恶性疾病,对患者的生活质量和整体健康有深远的影响。因此,寻求更有效的药物是非常重要和紧迫的。纳米酶,一类新的纳米材料,将纳米材料的生物学特性与酶的催化活性相结合,并被设计用于各种生物医学应用,包括复杂的胃肠道疾病(GI)。特别是,由于它们独特的金属配位结构和最大限度地提高原子利用效率的能力,具有原子分散的金属中心的单原子纳米酶(SAzymes)正在成为天然酶的更可行的替代品。由于制备过程的多样化和复杂性,传统的纳米酶设计策略不再能够满足当前对高效和多样化SAzyme设计的要求。因此,这篇综述强调了SAzymes的设计概念和合成策略,和相应的类似生物酶的活性,如超氧化物歧化酶(SOD),过氧化物酶(POD),氧化酶(OXD),过氧化氢酶(CAT),和谷胱甘肽过氧化物酶(GPx)。然后总结了SAzyes在胃肠道疾病中的各种应用,这应该鼓励进一步研究纳米酶,以实现更好的应用特性。
    Various clinical symptoms of digestive system, such as infectious, inflammatory, and malignant disorders, have a profound impact on the quality of life and overall health of patients. Therefore, the chase for more potent medicines is both highly significant and urgent. Nanozymes, a novel class of nanomaterials, amalgamate the biological properties of nanomaterials with the catalytic activity of enzymes, and have been engineered for various biomedical applications, including complex gastrointestinal diseases (GI). Particularly, because of their distinctive metal coordination structure and ability to maximize atom use efficiency, single-atom nanozymes (SAzymes) with atomically scattered metal centers are becoming a more viable substitute for natural enzymes. Traditional nanozyme design strategies are no longer able to meet the current requirements for efficient and diverse SAzymes design due to the diversification and complexity of preparation processes. As a result, this review emphasizes the design concept and the synthesis strategy of SAzymes, and corresponding bioenzyme-like activities, such as superoxide dismutase (SOD), peroxidase (POD), oxidase (OXD), catalase (CAT), and glutathione peroxidase (GPx). Then the various application of SAzymes in GI illnesses are summarized, which should encourage further research into nanozymes to achieve better application characteristics.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    基于OSMAC(一株多种化合物)策略,通过金属离子胁迫条件获得了海洋来源的真菌PenicilliumvelutinumJ.F.H.Beyma的四种提取物。使用LC/UV等现代方法的组合,LC/MS和生物活性数据分析,以及计算机模拟计算,分析了影响金属胁迫因素改变绒毛青霉代谢物分布的影响因素。从维卢坦的乙酸乙酯提取物中分离出两种新的哌嗪衍生物helvamidesB(1)和C(2)以及已知的saroclazinA(3)(4S,5R,7S)-4,11-二羟基-愈创亚-1(2),9(10)-dien(4)。它们的结构是基于光谱学方法建立的。HelvamideB(1)的绝对构型为2R,通过X射线分析和电子圆二色性(ECD)光谱的时间依赖性密度泛函理论(TD-DFT)计算的组合来确定5R。测定了分离的化合物对人前列腺癌PC-3和人胚肾HEK-293细胞的细胞毒性活性以及对酵母样真菌白色念珠菌的生长抑制活性。
    Four extracts of the marine-derived fungus Penicillium velutinum J.F.H. Beyma were obtained via metal ions stress conditions based on the OSMAC (One Strain Many Compounds) strategy. Using a combination of modern approaches such as LC/UV, LC/MS and bioactivity data analysis, as well as in silico calculations, influence metal stress factors to change metabolite profiles Penicillium velutinum were analyzed. From the ethyl acetate extract of the P. velutinum were isolated two new piperazine derivatives helvamides B (1) and C (2) together with known saroclazin A (3) (4S,5R,7S)-4,11-dihydroxy-guaia-1(2),9(10)-dien (4). Their structures were established based on spectroscopic methods. The absolute configuration of helvamide B (1) as 2R,5R was determined by a combination of the X-ray analysis and by time-dependent density functional theory (TD-DFT) calculations of electronic circular dichroism (ECD) spectra. The cytotoxic activity of the isolated compounds against human prostate cancer PC-3 and human embryonic kidney HEK-293 cells and growth inhibition activity against yeast-like fungi Candida albicans were assayed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    神经系统疾病,从中风和创伤性脑损伤等急性形式到痴呆等神经退行性疾病,是全球残疾调整寿命年(DALYs)的主要原因。解决这些情况和促进神经系统再生的有希望的方法是使用神经肽制剂脑活素,已在临床和临床前研究中被证明是有效的。尽管几种肽制剂声称具有相似的临床疗效和安全性,之前已经提出了对其通用成分和功效的担忧。根据这些报告,我们分析了几种据称类似于脑活素的肽制剂的肽组成和神经营养活性,并在一些国家批准用于治疗神经系统疾病。我们的结果表明,这些制剂缺乏相关的生物活性,并且肽组成与脑活素明显不同。肽。
    Neurological disorders, ranging from acute forms such as stroke and traumatic brain injury to neurodegenerative diseases like dementia, are the leading cause of disability-adjusted life years (DALYs) worldwide. A promising approach to address these conditions and promote nervous system regeneration is the use of the neuropeptide preparation Cerebrolysin, which has been shown to be effective in both clinical and preclinical studies. Despite claims of similar clinical efficacy and safety by several peptide preparations, concerns regarding their generic composition and efficacy have been previously raised. Based on these reports, we analyzed the peptide composition and neurotrophic activity of several peptide preparations allegedly similar to Cerebrolysin and approved in some countries for treating neurological diseases. Our results demonstrate that these preparations lack relevant biological activity and that the peptide composition is significantly different from Cerebrolysin. peptide.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    IL-1β是炎症信号通路中的重要分子,在炎性疾病中发挥重要作用。因此,靶向IL-1β的单克隆抗体(mAb)的开发已成为开发新型抗炎药的重点。治疗性抗体的成功临床应用依赖于良好的质量控制,这是基于准确的生物活性测定。这项工作的目的是开发一种优雅而准确的报告基因测定法,以确定抗IL-1β抗体药物的生物活性。选择IL-1受体天然高表达的D10-G4-1细胞系作为效应细胞,并将含有以NF-κB为调控元件的荧光素酶报告基因的质粒转染到D10-G4-1细胞中。经过一段时间的压力筛选,最终筛选出具有良好反应性和稳定表达报告基因的单克隆细胞系。通过添加IL-1β刺激该细胞系通过激活NF-κB信号通路增加了荧光素酶基因的表达,加入荧光素酶底物,可以通过相对发光单位来量化。当系统中存在抗IL-1β抗体时,荧光素酶基因的表达受到抑制,这证明了抗IL-1β抗体的生物活性。随后进行了详细的方法学优化和全面的方法学验证,以建立用于抗IL-1β抗体生物活性的报告基因测定。
    IL-1β is a essential molecule in inflammatory signalling pathways and plays an essential role in inflammatory diseases. Accordingly, the development of monoclonal antibodies (mAbs) that target IL-1β has become the focus of developing new anti-inflammatory drugs. The successful clinical application of therapeutic antibodies is dependent on good quality control, which is based on accurate bioactivity determination. The aim of this work was to develop an elegant and accurate reporter gene assay to determine the bioactivity of anti-IL-1β antibody drugs. The D10-G4-1 cell line with a naturally high expression of IL-1 receptor was selected as the effector cell, and the plasmid containing luciferase reporter gene with NF-κB as a regulatory element was transfected into D10-G4-1 cells. After a period of pressure screening, a monoclonal cell line with good reactivity and stable expression of reporter gene was finally screened out. Stimulation of this cell line via IL-1β addition increased the expression of the luciferase gene by activating the NF-κB signalling pathway, with the addition of luciferase substrate, which can be quantified by relative luminescence units. When anti-IL-1β antibodies are present in the system, the expression of luciferase gene is inhibited, which demonstrates the bioactivity of anti-IL-1β antibodies. Detailed methodological optimization and comprehensive methodological validation were followed to establish a reporter gene assay for the bioactivity of anti-IL-1β antibodies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    秋季粘虫(一汽),Spodopterafrugiperda(J.E.Smith),是影响全球玉米作物的最重要害虫之一。尽管种植表达苏云金芽孢杆菌(Bt)毒素的转基因玉米已被批准对FAW有效,它的人口对Bt作物的抗性已经在世界各地出现。因此,了解不同Bt蛋白之间的相互作用是很重要的,从而延缓抗性的发展。在这项研究中,我们进行了饮食覆盖生物测定来评估Cry1Ab的毒性,Cry1Ac,Cry1B,Cry1Ca,Cry1F,Cry2Aa,Cry2Ab,Vip3Aa11,Vip3Aa19和Vip3Aa20,以及Cry1Ab-之间的相互作用,Cry1F-,Cry2Ab-,和针对一汽的Vip3Aa类蛋白。根据我们的结果,Bt蛋白的LC50值从12.62ng/cm2到>9000ng/cm2(蛋白质/饮食),其中Vip3Aa类杀虫效果最好。Cry1Ab和Vip3Aa11的组合以5:1的比例表现出累加效应。Cry1F和Vip3Aa11组合在1:1、1:2和5:1的比率下表现出加性效应。Cry1F和Vip3Aa19的组合在比例为1:1时显示拮抗作用,在比例为1:2、2:1、1:5和5:1时显示累加作用。此外,Cry1F和Vip3Aa20的组合在1:2和5:1比例下显示拮抗作用,在1:1和2:1比例下显示加性效应。除了上述组合,具有累加或拮抗作用,其他组合表现出协同作用,协同因子(SFs)的变化。这些结果可用于建立具有合适候选物的新的金字塔转基因作物,为一汽控制和阻力管理策略提供依据。
    The fall armyworm (FAW), Spodoptera frugiperda (J.E. Smith), is one of the most important insect pests affecting corn crops worldwide. Although planting transgenic corn expressing Bacillus thuringiensis (Bt) toxins has been approved as being effective against FAW, its populations\' resistance to Bt crops has emerged in different locations around the world. Therefore, it is important to understand the interaction between different Bt proteins, thereby delaying the development of resistance. In this study, we performed diet-overlay bioassays to evaluate the toxicity of Cry1Ab, Cry1Ac, Cry1B, Cry1Ca, Cry1F, Cry2Aa, Cry2Ab, Vip3Aa11, Vip3Aa19, and Vip3Aa20, as well as the interaction between Cry1Ab-, Cry1F-, Cry2Ab-, and Vip3Aa-class proteins against FAW. According to our results, the LC50 values of Bt proteins varied from 12.62 ng/cm2 to >9000 ng/cm2 (protein/diet), among which the Vip3Aa class had the best insecticidal effect. The combination of Cry1Ab and Vip3Aa11 exhibited additive effects at a 5:1 ratio. Cry1F and Vip3Aa11 combinations exhibited additive effects at 1:1, 1:2, and 5:1 ratios. The combination of Cry1F and Vip3Aa19 showed an antagonistic effect when the ratio was 1:1 and an additive effect when the ratio was 1:2, 2:1, 1:5, and 5:1. Additionally, the combinations of Cry1F and Vip3Aa20 showed antagonistic effects at 1:2 and 5:1 ratios and additive effects at 1:1 and 2:1 ratios. In addition to the above combinations, which had additive or antagonistic effects, other combinations exhibited synergistic effects, with variations in synergistic factors (SFs). These results can be applied to the establishment of new pyramided transgenic crops with suitable candidates, providing a basis for FAW control and resistance management strategies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    由于在饮用水及其来源中经常检测到许多污染物,因此饮用水的安全性是人类健康非常关注的重要环境问题。在一些国家和地区,煮沸是一种常见的家用方法,用于生产相对高质量的饮用水。在这项研究中,借助基于高分辨率质谱和液相色谱的体外生物测定和非目标分析的集成方法,揭示了未经沸腾和沸腾的自来水样品中内分泌干扰活性的变化,以及导致这些改变的潜在内分泌干扰化学物质(EDCs)也得到了鉴定.自来水的有机提取物对雌激素受体(ER)没有明显的(抗)激动活性,孕激素受体(PR),糖皮质激素受体(GR),和盐皮质激素受体(MR)在≤10倍的富集浓度,对人类没有直接或严重的健康风险。然而,对PR和MR的激动活性和对ER的拮抗活性的存在,PR,GR,在相对较高的富集浓度下,自来水OEs中的MR仍然会引起潜在的健康问题。沸腾有效地降低了对这些类固醇激素受体(SHR)的拮抗活性,但增加了饮用水中的雌激素和糖皮质激素活性。四种新颖的潜在EDC,包括一个紫外线过滤器(苯基苯并咪唑磺酸,PBSA)和生物体的三种天然代谢产物(β-羟基肉豆蔻酸,12-羟基十八酸,和异色曼醇)在饮用水样品中鉴定,每个都对不同的SHR表现出(蚂蚁)激动活性。鉴于在防晒霜中广泛使用紫外线过滤剂来预防皮肤癌,PBSA作为已确定的新型EDC带来的健康风险令人担忧。尽管人们认为煮沸可以降低饮用水污染的健康风险,我们的发现表明,煮沸可能对饮用水的内分泌干扰活动有更复杂的影响,因此,需要进行更全面的评估。
    The safety of drinking water is a significant environmental issue of great concern for human health since numerous contaminants are often detected in drinking water and its sources. Boiling is a common household method used to produce relatively high-quality drinking water in some countries and regions. In this study, with the aid of an integrated approach of in vitro bioassays and non-target analysis based on high-resolution mass spectrometry coupled with liquid chromatography, alterations in endocrine-disrupting activities in tap water samples without and with boiling were revealed, as well as the potential endocrine-disrupting chemicals (EDCs) contributing to these alterations were identified. The organic extracts of tap water had no significant (ant)agonistic activities against an estrogen receptor (ER), progesterone receptor (PR), glucocorticoid receptor (GR), and mineralocorticoid receptor (MR) at enrichment concentrations of ≤10 times, posing no immediate or acute health risk to humans. However, the presence of agonistic activities against PR and MR and antagonistic activities against ER, PR, GR, and MR in OEs of tap water at relatively higher enrichment concentrations still raise potential health concerns. Boiling effectively reduced antagonistic activities against these steroid hormone receptors (SHRs) but increased estrogenic and glucocorticoid activities in drinking water. Four novel potential EDCs, including one UV filter (phenylbenzimidazole sulfonic acid, PBSA) and three natural metabolites of organisms (beta-hydroxymyristic acid, 12-hydroxyoctadecanoic acid, and isorosmanol) were identified in drinking water samples, each of which showed (ant)agonistic activities against different SHRs. Given the widespread use of UV filters in sunscreens to prevent skin cancer, the health risks posed by PBSA as an identified novel EDC are of concern. Although boiling has been thought to reduce the health risk of drinking water contamination, our findings suggest that boiling may have a more complex effect on the endocrine-disrupting activities of drinking water and, therefore, a more comprehensive assessment is needed.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    简介:国际人用药品技术要求协调理事会(ICH)于2012年启动了一项程序,以修订S1B指南“药品致癌性测试”。先前的回顾性分析表明,组织病理学危险因素在慢性毒性研究中的重要性,内分泌干扰的证据,和积极的遗传毒理学结果作为致癌风险的潜在预测指标。此外,已经报道了长期啮齿动物研究中药效学活性与致癌性结果之间的关系.据推测,这些因素可以通过证据权重(WoE)方法进行评估,以预测2年大鼠研究的结果。方法:ICHS1B(R1)专家工作组(EWG)进行了一项前瞻性评估研究(PES),以确定该WoE方法的监管可行性。药品监管机构(DRA)评估了49份致癌性评估文件(CADs),其中描述了提交的药物化合物的WoE。每种化合物都被归类为致癌风险类别,包括2年大鼠研究价值的陈述。评估已完成的2年大鼠研究的结果与前瞻性CAD相关,以确定预测的准确性。结果:根据PES的结果,EWG的结论是,ICHS1B中描述的评估药物人类致癌风险的评估过程可以扩展到包括WoE方法.在DRA和赞助商一致同意这样的研究不会增加价值的情况下,可以避免大约27%的2年大鼠研究。讨论:确定了支持WoE评估的关键因素:基于药物靶标生物学以及母体化合物和主要人类代谢产物的主要药理机制的数据告知致癌潜力;该化合物和主要人类代谢产物的二级药理学筛选结果告知致癌风险;来自重复剂量毒性研究的组织病理学数据;激素扰动的证据;遗传毒性数据;以及免疫调节的证据。PES的结果表明,可以使用WoE方法代替对某些药物进行为期2年的大鼠研究。这些数据被ICHS1B(R1)EWG用于编写2022年8月发布的S1B指南的R1附录。
    Introduction: The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) initiated a process in 2012 to revise the S1B Guideline \"Testing for Carcinogenicity of Pharmaceuticals\". Previous retrospective analysis indicated the importance of histopathological risk factors in chronic toxicity studies, evidence of endocrine perturbation, and positive genetic toxicology results as potentially predictive indicators of carcinogenic risk. In addition, a relationship between pharmacodynamic activity and carcinogenicity outcome in long-term rodent studies has been reported. It was postulated that these factors could be evaluated in a Weight-of-Evidence (WoE) approach to predict the outcome of a 2-year rat study. Methods: The ICH S1B(R1) Expert Working Group (EWG) conducted a Prospective Evaluation Study (PES) to determine the regulatory feasibility of this WoE approach. Drug Regulatory Authorities (DRAs) evaluated 49 Carcinogenicity Assessment Documents (CADs), which describe the WoE for submitted pharmaceutical compounds. Each compound was categorized into a carcinogenic risk category including a statement of the value of the 2-year rat study. The outcome of the completed 2-year rat studies was evaluated in relation to the prospective CAD to determine the accuracy of predictions. Results: Based on the results of the PES, the EWG concluded that the evaluation process for assessing human carcinogenic risk of pharmaceuticals described in ICH S1B could be expanded to include a WoE approach. Approximately 27% of 2-year rat studies could be avoided in cases where DRAs and sponsors unanimously agreed that such a study would not add value. Discussion: Key factors supporting a WoE assessment were identified: data that inform carcinogenic potential based on drug target biology and the primary pharmacologic mechanism of the parent compound and major human metabolites; results from secondary pharmacology screens for this compound and major human metabolites that inform carcinogenic risk; histopathology data from repeated-dose toxicity studies; evidence for hormonal perturbation; genotoxicity data; and evidence of immune modulation. The outcome of the PES indicates that a WoE approach can be used in place of conducting a 2-year rat study for some pharmaceuticals. These data were used by the ICH S1B(R1) EWG to write the R1 Addendum to the S1B Guideline published in August 2022.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:生物炭臭氧化先前被证明可以显着提高其阳离子交换能力,从而提高其营养保留能力。臭氧化生物炭的潜在土壤应用保证了需要进行毒性研究以调查其对微生物的影响。
    结果:在这里提出的研究中,我们发现,从臭氧化松400生物炭和臭氧化流氓生物炭收集的滤液对土壤环境细菌恶臭假单胞菌没有任何抑制作用,即使在300ppm的高溶解有机碳(DOC)浓度下。然而,在DOC浓度大于75ppm的情况下,臭氧化生物炭滤液抑制了长长复合球菌PCC7942的生长。进一步的测试表明,在非臭氧化松木400生物炭的滤液中存在一些潜在的抑制性化合物(对苯二甲酸和对甲苯甲酸);这些化合物在生物炭材料的湿法臭氧化后大大减少。营养检测测试还表明,流氓生物炭的干臭氧化增强了滤液中硝酸盐和磷酸盐的可用性,土壤应用所需的性质。
    结论:臭氧生物炭物质可以支持土壤环境细菌恶臭假单胞菌的生长,由于臭氧化使潜在的抑制性芳香分子解毒。
    BACKGROUND: Biochar ozonization was previously shown to dramatically increase its cation exchange capacity, thus improving its nutrient retention capacity. The potential soil application of ozonized biochar warrants the need for a toxicity study that investigates its effects on microorganisms.
    RESULTS: In the study presented here, we found that the filtrates collected from ozonized pine 400 biochar and ozonized rogue biochar did not have any inhibitory effects on the soil environmental bacteria Pseudomonas putida, even at high dissolved organic carbon (DOC) concentrations of 300 ppm. However, the growth of Synechococcus elongatus PCC 7942 was inhibited by the ozonized biochar filtrates at DOC concentrations greater than 75 ppm. Further tests showed the presence of some potential inhibitory compounds (terephthalic acid and p-toluic acid) in the filtrate of non-ozonized pine 400 biochar; these compounds were greatly reduced upon wet-ozonization of the biochar material. Nutrient detection tests also showed that dry-ozonization of rogue biochar enhanced the availability of nitrate and phosphate in its filtrate, a property that may be desirable for soil application.
    CONCLUSIONS: Ozonized biochar substances can support soil environmental bacterium Pseudomonas putida growth, since ozonization detoxifies the potential inhibitory aromatic molecules.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号